Toronto, June 24th, 2022 – Vivariant Laboratories Inc. – (the “Company” or “Vivariant”) is pleased to announce it has received its Drug Establishment License (DEL) number from Health Canada. In…

Toronto, March 4th, 2022 – Vivariant Laboratories Inc. – (the “Company” or “Vivariant”) is pleased to announce it has received its Drug Establishment License (DEL) application number (52704) from Health…

Toronto, February 2, 2022 – Vivariant Laboratories Inc. – (the “Company” or “Vivariant”) is pleased to announce it has achieved the performance benchmark of ISO/IEC 17025 accreditation by Canada Association…

Toronto, December 22nd, 2021 – Vivariant Laboratories Inc. – (the “Company” or “Vivariant”) is proud to announce it has submitted an application for a Licensed Dealer (LD) permit to possess…

Toronto, January 4, 2019 – Vivariant Laboratories Inc. – (the “Company” or “Vivariant”) is pleased to announce it has received its Containment Level II Pathogen and Toxin License from the…

Toronto, September 16, 2018 – Vivariant Laboratories Inc. – (the “Company” or “Vivariant”) is pleased to announce the submission of it’s Analytical Testing license application in Health Canada’s new Cannabis…

Toronto, May 29, 2018 – Vivariant Laboratories Inc. – (the “Company” or “Vivariant”) is pleased to announce the submission of an application for a Licensed Dealer (LD) Permit to Health…